Literature DB >> 6751517

Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas.

G Jautzke, E Altenaehr.   

Abstract

In 150 transitional cell carcinomas (TCC) of the urinary bladder, 50 each of Grades 1, 2, and 3, the content of carcinoembryonic antigen (CEA) was examined immunocytochemically and correlated to grading and staging. Fifty-seven percent of the TCC contained CEA-positive tumor cells. Their distribution in tumor tissue is described. They were found in 24% of Grade 1 cases, in 72% of Grade 2 carcinomas, and in 76% of Grade 3 tumors. None of the Grade 1 cases contained more than 10% CEA-positive cells, whereas 34% and 40% of the Grade 2 and 3 tumors, respectively, revealed more than 10% CEA-positive tumor cells. According to the correlation found between grading and staging, the percentage of TCC containing CEA-positive tumor cells was 34% in pTA, 59% in pT1, and 80% in pT2/3 tumors. The results show a correlation between CEA content of tumor tissue and histopathologic malignancy in TCC of urinary bladder.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6751517     DOI: 10.1002/1097-0142(19821115)50:10<2052::aid-cncr2820501015>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Neoplastic invasion of the connective stalks in transitional cell papillary tumors (TCPT) of the bladder.

Authors:  A Tommasini-Degna; R Negri
Journal:  Urol Res       Date:  1987

2.  Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder.

Authors:  J Steffens; W Friedmann; H Lobeck
Journal:  Urol Res       Date:  1985

3.  Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.

Authors:  Guru P Sonpavde; Benjamin Louis Maughan; Bradley Alexander McGregor; Xiao X Wei; Kerry L Kilbridge; Richard J Lee; Evan Y Yu; Michael Thomas Schweizer; Robert B Montgomery; Heather H Cheng; Andrew Caleb Hsieh; Rohit Jain; Jaspreet S Grewal; Cesar Pico-Navarro; Zarina Gafoor; Teresa Perschy; Petros Grivas
Journal:  Cancer Immunol Immunother       Date:  2022-08-23       Impact factor: 6.630

Review 4.  Invasiveness of transformed bladder epithelial cells.

Authors:  J F Kieler
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

5.  Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumors.

Authors:  C Cordon-Cardo; D D Wartinger; M R Melamed; W Fair; Y Fradet
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

6.  Comparison between cell kinetical and immunohistochemical studies on carcinoma and atypia/dysplasia of urinary bladder mucosa.

Authors:  B Helpap; J Vogel; P Oehr; H D Adolphs
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

7.  Urine carcinoembryonic antigen levels are more useful than serum levels for early detection of Bilharzial and non-Bilharzial urinary bladder carcinoma: observations of 43 Egyptian cases.

Authors:  Gamal M Saied; Wafaa H El-Metenawy; Mohamed S Elwan; Nazar R Dessouki
Journal:  World J Surg Oncol       Date:  2007-01-15       Impact factor: 2.754

8.  Nonmuscle invasive bladder cancer: a primer on immunotherapy.

Authors:  Mahir Maruf; Sam J Brancato; Piyush K Agarwal
Journal:  Cancer Biol Med       Date:  2016-06       Impact factor: 4.248

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.